Biotalys announces participation at investor and industry events for the upcoming months
Ghent, Belgium, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Biotalys (Euronext - BTLS), an Agricultural Technology (AgTech) company protecting crops and food with protein-based biocontrol solutions, today announces the upcoming participation of the company in a variety of European investor and business events. Biotalys welcomes the opportunity to engage with institutional and retail investors during these events to share the company’s exciting development since its IPO in July 2021.
Berenberg Food Ingredients & Chemicals Conference 2022
September 13-14, 2022
London, UK
Group presentation by Biotalys’ management and 1-2-1 meetings with investors
Kepler Cheuvreux Autumn Conference
September 15, 2022
Paris, France
Group presentation by Biotalys’ management and 1-2-1 meetings with investors
World Agri-Tech Innovation Summit
September 20-21, 2022
London, UK
Panel debate with Patrice Sellès, CEO of Biotalys
L’investisseur on Tour
September 26, 2022
Braine-L'Alleud, Belgium or via livestream
Presentation by Patrice Sellès (event in French)
KBC Securities Sustainability Conference
September 29, 2022
Virtual
Group presentation by Biotalys’ management and 1-2-1 meetings with investors
Annual Biocontrol Industry Meeting (ABIM)
October 24-26, 2022
Basel, Switzerland
Participation by Biotalys’ management
FoodTech Congress
October 27, 2022
Virtual
Keynote speech by Patrice Sellès
VFB Soirée
October 27, 2022
Webinar organized by the Flemish Retail Investor Association (VFB) with Patrice Sellès
About Biotalys
Biotalys is an Agricultural Technology (AgTech) company protecting crops and food with proprietary protein-based biocontrol solutions and aiming to provide alternatives to conventional chemical pesticides for a more sustainable and safer food supply. Based on its novel AGROBODY™ technology platform, Biotalys is developing a strong and diverse pipeline of effective product candidates with a favorable safety profile that aim to address key crop pests and diseases across the whole value chain, from soil to plate. Biotalys was founded in 2013 as a spin-off from the VIB (Flanders Institute for Biotechnology) and is listed on Euronext Brussels since July 2021. The company is based in the biotech cluster in Ghent, Belgium. More information can be found on www.biotalys.com.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
For further information, please contact
Toon Musschoot, Head of IR & Communication
T: +32 (0)9 274 54 00
E: Toon.Musschoot@biotalys.com
Important Notice
This announcement contains statements which are "forward-looking statements" or could be considered as such. These forward-looking statements can be identified by the use of forward-looking terminology, including the words ‘aim’, 'believe', 'estimate', 'anticipate', 'expect', 'intend', 'may', 'will', 'plan', 'continue', 'ongoing', 'possible', 'predict', 'plans', 'target', 'seek', 'would' or 'should', and contain statements made by the company regarding the intended results of its strategy. By their nature, forward-looking statements involve risks and uncertainties and readers are warned that none of these forward-looking statements offers any guarantee of future performance. The Biotalys actual results may differ materially from those predicted by the forward-looking statements. Biotalys makes no undertaking whatsoever to publish updates or adjustments to these forward-looking statements, unless required to do so by law.
Attachments
- Biotalys persbericht - deelname aan komende investeerders- en sectorconferenties
- Biotalys Press Release - upcoming investor and industry events
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Composition of the Nomination Committee of Orion Corporation26.4.2024 10:15:00 CEST | Press release
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 26 APRIL 2024 at 11.15 EEST Composition of the Nomination Committee of Orion Corporation The Board of Directors of Orion Corporation has appointed the following persons to the Nomination Committee of the company: Annika EkmanPetteri KarttunenMinna MaasiltaVeli-Matti MattilaHilpi RautelinSeppo Salonen Hilpi Rautelin was appointed as Chair of the Committee. The Committee prepares and presents a recommendation to the Board of Directors for the proposal to the Annual General Meeting concerning the composition of the Board. The essentials of the charter of the Nomination Committee and a description of the appointment process of its members are provided at https://www.orion.fi/en/investors/corporate-governance/board-of-directors/nomination-committee/charter-of-the-nomination-committee/ , a page in the Corporate Governance section of the Orion Group website. Orion Corporation Liisa Hu
RESULT OF RIKSBANK AUCTIONS GOVERNMENT BONDS26.4.2024 10:05:00 CEST | Press release
Auction date2024-04-26Loan3104Coupon3.50 %ISIN-codeSE0000556599 Maturity2028-12-01Tendered volume, SEK mln400 +/- 400 Total bid volume, SEK mln1,025Volume sold, SEK mln400 Number of bids21 Number of accepted bids7 Average yield1,160 %Lowest yield1,129 %Highest accepted yield1,163 %% accepted at highest yield 73,00
SKEL fjárfestingafélag hf.: Trading statement Q1 202426.4.2024 10:02:04 CEST | Press release
Enclosed is the trading statement of Skel fjárfestingafélag hf. for the first quarter of 2024. For further information, or to request a meeting, please contact fjarfestar@skel.is Attachment SKEL Trading Statement Q1
Proposals to the Annual General Meeting of Municipality Finance Plc26.4.2024 10:00:00 CEST | Press release
Municipality Finance Plc Stock Exchange Release 26 April 2024 at 11:00 am (EEST) Proposals to the Annual General Meeting of Municipality Finance Plc Municipality Finance Plc’s (hereinafter MuniFin) Board of Directors (the Board) and the Shareholders’ Nomination Committee (the Nomination Committee) have made the following proposals to the Annual General Meeting (the AGM) convening on 17 May 2024 at 10:00 (EET): Use of profit shown on the balance sheet and the distribution of dividend MuniFin has distributable funds of EUR 365,610,693.66 of which the profit for the financial year totaled EUR 67,416,447.86. In accordance with the dividend policy adopted by the AGM in March 2023, MuniFin’s aim is to pay 30-60% of the Group’s financial year’s profit in dividends. The Board proposes to the AGM that a dividend of EUR 1.69 per share, totaling EUR 66,017,818.62 shall be distributed based on the balance sheet to be adopted for 2023. MuniFin’s profit for the financial year is strong. The Board co
Meddelelse nr. 07/2023: Delårsrapport 1. januar – 31. marts 202426.4.2024 09:57:33 CEST | pressemeddelelse
Bestyrelsen for Strategic Investments A/S har på et møde d.d. behandlet selskabets delårsrapport for perioden 1. januar – 31. marts 2024. Resumé: Strategic Investments resultat for 1. kvartal 2024 blev på DKK -70,4m før og efter skat, svarende til et afkast på -14,5%.Bag det negative resultat ligger en generel negativ udvikling for small cap aktier og en negativ kursudvikling på tværs af selskabets aktieportefølje, der primært indeholder small cap aktier.Selskabets egenkapital var d. 31. marts 2024 DKK 416,7m, svarende til en indre værdi af selskabets aktier på DKK 1,05 pr. aktie. Bestyrelsen har, i overensstemmelse med selskabets udbyttepolitik, indstillet udbetaling af et udbytte på DKK 0,02 på selskabets generalforsamling d.d.Strategic Investments forventer for 2024 uændret et resultat, der lever op til selskabets langsigtede målsætning om over tid at skabe et årligt afkast på 10-15%, svarende til et resultat for 2024 på DKK 47-73m. Spørgsmål vedrørende denne meddelelse kan rettes t